Paper · 12930397
All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells.
Mohty M and 6 others. Br J Haematol, 2003. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Papers, record 12930397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12930397
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Leukocytes, Mononuclear | Major topic |
| Tretinoin | Major topic |
| CD4-Positive T-Lymphocytes | |
| Cell Differentiation | |
| Cell Division | |
| Cells, Cultured | |
| Dendritic Cells | |
| Flow Cytometry | |
| Granulocyte-Macrophage Colony-Stimulating Factor | |
| Humans | |
| Interferon-gamma | |
| Interleukin-12 | |
| Interleukin-4 | |
| Lymphocyte Culture Test, Mixed | |
| Th1 Cells | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,978,914 | All-trans retinoic acid in solid-tumour immunity: context-dependent signalling, cellular states, and combination therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42978914 | PubMed |
| 42,840,641 | Retinoic acid regulates donor myeloid-derived suppressor cell and colonic dendrite cell reconstitution after allogeneic hematopoietic stem cell transplantation in mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840641 | PubMed |
| 40,574,966 | Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival update. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/40574966 | PubMed |
| 38,600,116 | A Lacticaseibacillus rhamnosus secretome induces immunoregulatory transcriptional, functional and immunometabolic signatures in human THP-1 monocytes. | Sci Rep | 2024 | https://conductscience.org/library/papers/38600116 | PubMed |
| 38,492,186 | Immunomodulatory and Anti-Inflammatory Effects of Vitamin A and Tryptophan on Monocyte-Derived Dendritic Cells Stimulated with Gliadin in Celiac Disease Patients. | Inflammation | 2024 | https://conductscience.org/library/papers/38492186 | PubMed |
| 37,952,906 | Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37952906 | PubMed |
| 37,214,093 | The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia. | PeerJ | 2023 | https://conductscience.org/library/papers/37214093 | PubMed |
| 36,168,619 | Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness. | Theranostics | 2022 | https://conductscience.org/library/papers/36168619 | PubMed |
| 33,679,618 | Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33679618 | PubMed |
| 33,312,338 | NOX2-Derived Reactive Oxygen Species in Cancer. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33312338 | PubMed |
1 to 10 of 30
See all 30 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD1A | 909 | PubTator's text mining | https://conductscience.org/library/genes/909 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CSF2 | 1,437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL12B | 3,593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12930397
GET https://conductscience.org/api/papers/v1/12930397/cited_by?page=2